SSX2IP as a novel prognosis biomarker plays an important role in the development of breast cancer
ConclusionThese data indicated that SSX2IP promotes tumor progression in BC, include cell activity, proliferation, migratory and invasive, clone formation abilities were inhibited, and the cell apoptosis increased. This work further suggest that SSX2IP could be used to be a potential therapeutic targets in BC.
Source: Molecular and Cellular Toxicology - Category: Cytology Source Type: research
More News: Acute Leukemia | Acute Myeloid Leukemia | Breast Cancer | Cancer | Cancer & Oncology | Cytology | Genetics | Leukemia | Study | Toxicology